Metal–ligand interactions in drug design

L Riccardi, V Genna, M De Vivo - Nature Reviews Chemistry, 2018 - nature.com
The fast-growing body of experimental data on metalloenzymes and organometallic
compounds is fostering the exploitation of metal–ligand interactions for the design of new …

Exploiting the microhomology-mediated end-joining pathway in cancer therapy

J Patterson-Fortin, AD D'Andrea - Cancer research, 2020 - AACR
Repair of DNA double-strand breaks (DSB) is performed by two major pathways, homology-
dependent repair and classical nonhomologous end-joining. Recent studies have identified …

[HTML][HTML] Oxidized DNA fragments exit mitochondria via mPTP-and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling

H Xian, K Watari, E Sanchez-Lopez, J Offenberger… - Immunity, 2022 - cell.com
Mitochondrial DNA (mtDNA) escaping stressed mitochondria provokes inflammation via
cGAS-STING pathway activation and, when oxidized (Ox-mtDNA), it binds cytosolic NLRP3 …

[HTML][HTML] The importance of poly (ADP-ribose) polymerase as a sensor of unligated Okazaki fragments during DNA replication

H Hanzlikova, I Kalasova, AA Demin, LE Pennicott… - Molecular cell, 2018 - cell.com
Poly (ADP-ribose) is synthesized by PARP enzymes during the repair of stochastic DNA
breaks. Surprisingly, however, we show that most if not all endogenous poly (ADP-ribose) is …

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

ST Durant, L Zheng, Y Wang, K Chen, L Zhang… - Science …, 2018 - science.org
Poor survival rates of patients with tumors arising from or disseminating into the brain are
attributed to an inability to excise all tumor tissue (if operable), a lack of blood-brain barrier …

Genetic screens reveal FEN1 and APEX2 as BRCA2 synthetic lethal targets

KE Mengwasser, RO Adeyemi, Y Leng, MY Choi… - Molecular cell, 2019 - cell.com
BRCA1 or BRCA2 inactivation drives breast and ovarian cancer but also creates
vulnerability to poly (ADP-ribose) polymerase (PARP) inhibitors. To search for additional …

FEN 1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer

L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - Wiley Online Library
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …

Characterization of the SARS-CoV-2 ExoN (nsp14ExoN–nsp10) complex: implications for its role in viral genome stability and inhibitor identification

HT Baddock, S Brolih, Y Yosaatmadja… - Nucleic acids …, 2022 - academic.oup.com
The SARS-CoV-2 coronavirus is the causal agent of the current global pandemic. SARS-
CoV-2 belongs to an order, Nidovirale s, with very large RNA genomes. It is proposed that …

FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination

E Guo, Y Ishii, J Mueller, A Srivatsan… - Proceedings of the …, 2020 - National Acad Sciences
Synthetic lethality strategies for cancer therapy exploit cancer-specific genetic defects to
identify targets that are uniquely essential to the survival of tumor cells. Here we show …

Phosphate steering by Flap Endonuclease 1 promotes 5′-flap specificity and incision to prevent genome instability

SE Tsutakawa, MJ Thompson, AS Arvai, AJ Neil… - Nature …, 2017 - nature.com
DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome
integrity, and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single …